XML 52 R21.htm IDEA: XBRL DOCUMENT
v3.23.2

Description of Organization, Business Operations and Liquidity (Details Narrative) |  |  |  |  |  |  |  |  |  | 6 Months Ended | 8 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 28, 2023 USD ($) $ / shares shares | Jun. 20, 2023 $ / shares shares | Jun. 07, 2023 shares | May 04, 2023 $ / shares shares | Apr. 04, 2023 | Feb. 03, 2023 USD ($) $ / shares shares | Jan. 30, 2023 shares | Nov. 08, 2021 USD ($) $ / shares shares | Nov. 05, 2021 shares | Jun. 30, 2023 USD ($) Integer $ / shares shares | Jun. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) Integer $ / shares shares | Mar. 23, 2023 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Condition for future business combination number of businesses minimum | Integer |  |  |  |  |  |  |  |  |  | 1 |  |  | 1 |
Number of shares issued | shares |  | 750,000 |  |  |  |  |  |  |  |  |  |  |  |
Deferred underwriting fee payable |  |  |  |  |  |  |  |  |  | $ 14,700,000 |  | $ 14,700,000 | $ 14,700,000 |
Payments for investment of cash in trust account |  |  |  |  |  |  |  |  |  |  |  | 351,900,000 |  |
Condition for future business combination use of proceeds percentage |  |  |  |  |  |  |  |  |  | 80.00% |  |  | 80.00% |
Condition for future business combination threshold ownership (as a percent) |  |  |  |  |  |  |  |  |  | 50.00% |  |  | 50.00% |
Maximum net tangible assets |  |  |  |  |  |  |  |  |  | $ 5,000,001 |  |  | $ 5,000,001 |
Conversion ratio |  |  |  |  |  |  | 1 |  |  |  |  |  |  |
Cash withdrawn from Trust Account in connection with redemption |  |  |  |  |  |  |  |  |  | 333,270,649 |  |  |  |
Cash and marketable securities held in Trust Account |  |  |  |  |  | $ 25,000,000 |  |  |  | $ 25,675,938 |  | 351,915,805 | $ 356,864,000 |
Past fee due balance |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 151,000
Written notice description |  |  |  |  | On April 4, 2023, the Company received a written notice (the “April Notice”) from the Nasdaq indicating that the Company was not in compliance with Listing Rule 5450(b)(2)(A), requiring the Company to maintain a Market Value of Listed Securities (“MVLS”) of $50,000,000 for the continued listing of its securities on The Nasdaq Global Market. The April Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq. The April Notice states that the Company has 180 calendar days, or until October 2, 2023, to regain compliance with Listing Rule 5450(b)(2)(A). If at any time during this compliance period the Company’s MLVS closes at $50,000,000 or more for a minimum of ten consecutive business days, Nasdaq will provide the Company with a written confirmation of compliance, and this matter will be closed. |  |  |  |  |  |  |  |  |
Redemption limit percentage without prior consent |  |  |  |  |  |  |  |  |  | 15.00% |  |  | 15.00% |
Obligation to redeem public shares if entity does not complete a business combination |  |  |  |  |  |  |  |  |  | 100.00% |  |  | 100.00% |
Maximum allowed dissolution expenses |  |  |  |  |  |  |  |  |  | $ 100,000 |  |  | $ 100,000 |
Cash held in operating bank accounts |  |  |  |  |  |  |  |  |  | 25,000,000 |  |  | 129,186 |
Cash |  |  |  |  |  |  |  |  |  | 556,010 |  | $ 344,581 | 129,186 |
[custom:WorkingCapital-0] |  |  |  |  |  |  |  |  |  | 821,285 |  |  |  |
Income on investments held in Trust Account |  |  |  |  |  |  |  |  |  | $ 2,100,000 |  |  | $ 4,948,000 |
Months to complete acquisition |  |  |  |  |  |  |  |  |  |  |  |  | 15 months |
Redemption period upon closure |  |  |  |  |  |  |  |  |  |  |  |  | 10 days |
Working capital |  |  |  |  |  |  |  |  |  |  |  |  | $ 76,098 |
Tevogen Bio Securities [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business combination, consideration transferred | $ 1,200,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued for acquisition | shares | 20,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Business combination, description | (a) $15.00 per share for 20 out of any 30 consecutive trading days beginning on the Closing Date of the Merger Agreement until the 36-month anniversary of the Closing Date, in which case the holders of Tevogen Bio securities shall be entitled to receive an additional 6,666,667 shares of Common Stock, (b) $17.50 per share for 20 out of any 30 consecutive trading days beginning on the Closing Date of the Merger Agreement until the 36-month anniversary of the Closing Date, in which case the holders of Tevogen Bio securities shall be entitled to receive an additional 6,666,667 shares of Common Stock and (c) $20.00 per share for 20 out of any 30 consecutive trading days beginning on the Closing Date of the Merger Agreement until the 36-month anniversary of the Closing Date, in which case the holders of Tevogen Bio securities shall be entitled to receive an additional 6,666,666 shares of Common Stock. In addition, for each Earnout Share Payment, the Company will also issue to Sponsor an additional 1,500,000 shares of Company Common Stock. |  |  |  |  |  |  |  |  |  |  |  |  |
Sponsor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares | 1,500,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued to purchase ordinary shares (in shares) | shares |  |  |  |  |  |  |  |  |  | 725,000 |  |  | 725,000 |
Tevogeb Bio Holdings Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price, per unit | $ / shares | $ 11.50 |  |  |  |  |  |  |  |  |  |  |  |  |
Charter Amendment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum period to file charter amendment |  |  |  |  |  | 15 days |  |  |  |  |  |  |  |
Cash withdrawn from Trust Account in connection with redemption |  |  |  |  |  | $ 332,000,000 |  |  |  |  |  |  |  |
Common Class A [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued upon conversion | shares |  |  |  |  |  |  | 11,983,333 |  |  |  |  |  |  |
Common stock shares issued | shares |  |  |  |  |  |  | 47,933,333 |  |  | 13,433,333 |  | 1,450,000 | 1,450,000 |
Common stock shares outstanding | shares |  |  |  |  |  |  | 47,933,333 |  |  | 13,433,333 |  | 1,450,000 | 1,450,000 |
Common stock, par value | $ / shares | 0.0001 | $ 0.0001 |  |  |  |  |  |  |  | $ 0.0001 |  | $ 0.0001 | $ 0.0001 |
Exrecise price | $ / shares | $ 11.50 |  |  |  |  |  |  |  |  |  |  |  |  |
Common Class B [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares cancelled | shares |  |  |  |  |  |  | 11,983,333 |  |  |  |  |  |  |
Common stock shares issued | shares |  |  |  |  |  |  | 0 |  |  | 0 |  | 11,983,333 | 11,983,333 |
Common stock shares outstanding | shares |  |  |  |  |  |  | 0 |  |  | 0 |  | 11,983,333 | 11,983,333 |
Common stock, par value | $ / shares |  |  |  |  |  |  |  |  |  | $ 0.0001 |  | $ 0.0001 | $ 0.0001 |
Public Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares outstanding | shares |  |  |  |  |  | 2,383,053 |  |  |  |  |  |  |  |
Public Shares [Member] | Charter Amendment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares held by the shareholders exercised their right to redeem shares | shares |  |  |  |  |  | 32,116,947 |  |  |  |  |  |  |  |
Price per share | $ / shares |  |  |  |  |  | $ 10.34 |  |  |  |  |  |  |  |
SSVK Associates, LLC [Member] | Purchase Agreement [Member] | Sponsor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  | 7,988,889 |  |  |  |  |  |  |  |  |  |  |
SSVK Associates, LLC [Member] | Common Class A [Member] | Purchase Agreement [Member] | Sponsor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued to purchase ordinary shares (in shares) | shares |  |  | 500,000 |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  | 1,000,000 | 7,988,889 |  |  |  |  |  |  |  |  |  |
Purchase price, per unit | $ / shares |  |  |  | $ 1.00 |  |  |  |  |  |  |  |  |  |
IPO [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of units, net of underwriting discounts (in shares) | shares |  |  |  |  |  |  |  | 30,000,000 |  |  |  |  |  |
Proceeds from issuance initial public offering |  |  |  |  |  |  |  | $ 300,000,000 |  |  |  |  |  |
Purchase price, per unit | $ / shares |  |  |  |  |  |  |  | $ 10.00 |  | $ 10.20 |  |  | $ 10.20 |
Deferred underwriting fee payable |  |  |  |  |  |  |  | $ 14,700,000 |  |  |  |  |  |
Offering costs |  |  |  |  |  |  |  | 21,266,594 |  |  |  |  |  |
Underwriting fees |  |  |  |  |  |  |  | 6,000,000 |  |  |  |  |  |
Other offering costs |  |  |  |  |  |  |  | 566,594 |  |  |  |  |  |
Payments for investment of cash in trust account |  |  |  |  |  |  |  | $ 351,900,000 |  |  |  |  |  |
IPO [Member] | Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price, per unit | $ / shares |  |  |  |  |  |  |  | $ 10.20 |  |  |  |  |  |
Payments for investment of cash in trust account |  |  |  |  |  |  |  | $ 351,900,000 |  |  |  |  |  |
IPO [Member] | Fee Reduction Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares | 500,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred underwriting fee payable | $ 5,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred underwriting fee forfeited | $ 9,700,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Private Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued to purchase ordinary shares (in shares) | shares |  |  |  |  |  |  |  | 1,360,000 |  |  |  |  |  |
Price of warrant | $ / shares |  |  |  |  |  |  |  | $ 10.00 |  |  |  |  |  |
Proceeds from sale of warrants |  |  |  |  |  |  |  | $ 13,600,000 |  |  |  |  |  |
Private Placement [Member] | Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued to purchase ordinary shares (in shares) | shares |  |  |  |  |  |  |  | 1,450,000 |  |  |  |  |  |
Price of warrant | $ / shares |  |  |  |  |  |  |  | $ 10.00 |  |  |  |  |  |
Proceeds from sale of warrants |  |  |  |  |  |  |  | $ 14,500,000 |  |  |  |  |  |
Private Placement [Member] | Sponsor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of units, net of underwriting discounts (in shares) | shares |  |  |  |  |  |  |  | 90,000 |  |  |  |  |  |
Proceeds from issuance initial public offering |  |  |  |  |  |  |  | $ 900,000 |  |  |  |  |  |
Private Placement [Member] | Sponsor [Member] | Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued to purchase ordinary shares (in shares) | shares |  |  |  |  |  |  |  | 1,300,000 |  |  |  |  |  |
Private Placement [Member] | SSVK Associates, LLC [Member] | Purchase Agreement [Member] | Sponsor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  | 1,000,000 |  |  |  |  |  |  |  |  |  |
Over-Allotment Option [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of units, net of underwriting discounts (in shares) | shares |  |  |  |  |  |  |  | 4,500,000 | 4,500,000 | 4,500,000 |  |  | 4,500,000 |
Proceeds from issuance initial public offering |  |  |  |  |  |  |  | $ 45,000,000 |  |  |  |  |  |
Deferred underwriting fee payable |  |  |  |  |  |  |  | $ 2,700,000 |  |  |  |  |  |
Common Stock [Member] | Common Class B [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  | 11,983,333 |  |
Common Stock [Member] | IPO [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of units, net of underwriting discounts (in shares) | shares |  |  |  |  |  |  |  | 30,000,000 |  |  |  |  |  |
Purchase price, per unit | $ / shares |  |  |  |  |  |  |  | $ 10.00 |  |  |  |  |  |
Proceeds from issuance initial public offering |  |  |  |  |  |  |  | $ 300,000,000 |  |  |  |  |  |

X
- Definition Represents the price per share or per unit of warrants or rights outstanding. + References No definition available. + Details
Name: | LGST_ClassOfWarrantOrRightPriceOfWarrantsOrRights
Namespace Prefix: | LGST_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering. + References No definition available. + Details
Name: | LGST_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
Namespace Prefix: | LGST_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering. + References No definition available. + Details
Name: | LGST_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering. + References No definition available. + Details
Name: | LGST_ConditionForFutureBusinessCombinationThresholdPercentageOwnership
Namespace Prefix: | LGST_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination. + References No definition available. + Details
Name: | LGST_ConditionForFutureBusinessCombinationUseOfProceedsPercentage
Namespace Prefix: | LGST_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent. + References No definition available. + Details
Name: | LGST_DeferredOfferingCostsNoncurrent
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | LGST_DeferredOfferingCostsNoncurrentForfeited
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- References No definition available. + Details
Name: | LGST_ExrecisePricePerShare
Namespace Prefix: | LGST_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period. + References No definition available. + Details
Name: | LGST_MaximumAllowedDissolutionExpenses
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum period to file charter amendment with the cayman islands general registry from the meeting. + References No definition available. + Details
Name: | LGST_MinimumPeriodToFileCharterAmendmentWithCaymanIslandsGeneralRegistry
Namespace Prefix: | LGST_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Months to complete acquisitions. + References No definition available. + Details
Name: | LGST_MonthsToCompleteAcquisitions
Namespace Prefix: | LGST_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | LGST_NasdaqWrittenNoticeDescription
Namespace Prefix: | LGST_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of past fee due balance. + References No definition available. + Details
Name: | LGST_PastFeeDueBalance
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of cash outflow for investment of cash in trust account. + References No definition available. + Details
Name: | LGST_PaymentsForInvestmentOfCashInTrustAccount
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period. + References No definition available. + Details
Name: | LGST_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
Namespace Prefix: | LGST_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of price per share. + References No definition available. + Details
Name: | LGST_PricePerShare
Namespace Prefix: | LGST_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from cash withdrawn from Trust Account in connection with redemption. + References No definition available. + Details
Name: | LGST_ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The limit on the percentage of shares which may be redeemed with out prior consent of the reporting entity. + References No definition available. + Details
Name: | LGST_RedemptionLimitPercentageWithoutPriorConsent
Namespace Prefix: | LGST_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Redemption period upon closure. + References No definition available. + Details
Name: | LGST_RedemptionPeriodUponClosure
Namespace Prefix: | LGST_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the amount of other offering costs incurred. + References No definition available. + Details
Name: | LGST_SaleOfStockOtherOfferingCosts
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the amount of offering fees incurred and paid for underwriters. + References No definition available. + Details
Name: | LGST_SaleOfStockUnderwritingFees
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares held by the shareholders exercised their right to redeem shares. + References No definition available. + Details
Name: | LGST_ShareholdersExercisedTheirRightToRedeemSharesNumberOfShares
Namespace Prefix: | LGST_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the amount of transaction costs incurred. + References No definition available. + Details
Name: | LGST_TransactionCosts
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of new units issued during the period. + References No definition available. + Details
Name: | LGST_UnitsIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | LGST_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | LGST_WorkingCapital
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Working capital deficit. + References No definition available. + Details
Name: | LGST_WorkingCapitalDeficit
Namespace Prefix: | LGST_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 + Details
Name: | us-gaap_AssetsHeldInTrustNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2 + Details
Name: | us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 45 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 20 -SubTopic 210 -Topic 946 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20 + Details
Name: | us-gaap_Cash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4 + Details
Name: | us-gaap_CashAndCashEquivalentsAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_InvestmentIncomeInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceInitialPublicOffering
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of stock issued during the period pursuant to acquisitions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesAcquisitions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of stock bought back by the entity at the exercise price or redemption price. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_StockRedeemedOrCalledDuringPeriodShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4 + Details
Name: | us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=LGST_TevogenBioSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=LGST_SponsorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=LGST_PrivatePlacementWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=LGST_TevogebBioHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=LGST_CharterAmendmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=LGST_PublicSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=LGST_SsvkAssociatesLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=LGST_PurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=LGST_SponsorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=LGST_FeeReductionAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LGST_SponsorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |